Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
Related Posts
Add A Comment
Subscribe to Updates
Get the latest news from PRIMA NEWS about politics, art, design and business.

